Erweiterte Suche
Einloggen
Einloggen
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registrieren
E-Mail Registrierung
Oder einloggen mit
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Startseite
  2. Aktien
  3. Vereinigte Staaten
  4. Nasdaq
  5. BioNTech SE
  6. Fonds
  7. Fonds Positionnés
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Bericht
Verzögert Nasdaq  -  22:00:00 31.03.2023
124.57 USD   +1.63%
17:01BioNTech SE : UBS bekräftigt seine neutrale Bewertung
MM
29.03.Biontech : Geschäftsbericht 2022
PU
29.03.BioNTech SE: Der Tag danach
MS
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivateFonds 
ETFs investiert in BIONTECH SEETFs und Tracker mit Trackinsight
ETF GewichtVeränd. 5 TageRatingGeographie
VanEck Genomics and Healthcare Innovators - USD4.83%-0.02%-NC
Global X Genomics & Biotechnology - USD3.97%-0.32%-NC
Global X Genomics & Biotechnology ETF - USD3.96%0.76%NC
VanEck Biotech ETF - USD3.84%2.05%United States
IShares Genomics Immunology and Healthcare ...3.57%1.19%Welt
ETFMG Treatments Testing and Advancements E...3.31%2.39%-NC
First Trust NYSE Arca Biotechnology Index F...3.3%2.51%United States
First Trust NYSE Arca Biotechnology - Acc - USD3.07%1.82%-United States
Direxion Nanotechnology ETF - USD2.93%1.37%-NC
First Trust IPOX Europe Equity Opportunitie...2.77%1.08%-NC
Loncar Cancer Immunotherapy ETF - USD2.58%3.35%-Welt
CI Bio-Revolution ETF - CAD2.5%0.00%-NC
First Trust IPOX� Europe Equity...2.44%2.60%Europa
IShares Biotechnology ETF - USD2.37%2.32%-NC
VanEck Global Healthcare Leaders ETF - AUD1.98%1.76%-NC
Lyxor F.A.Z. 100 Index (DR) - EUR1.95%1.68%-Deutschland
VictoryShares Nasdaq Next 50 ETF - USD1.45%2.52%-NC
Deka Germany 30 - EUR1.2%1.91%-Deutschland
IShares Nasdaq US Biotechnology (D) - USD1.2%2.05%United States
IShares Nasdaq US Biotechnology - USD1.2%2.07%United States
Invesco Nasdaq Biotechnology ETF - USD1.19%1.95%-United States
BMO MSCI Genomic Innovation Index ETF - CAD1.19%-0.30%-NC
Amundi US Tech 100 Equal Weight DR - USD0.97%10.30%-NC
Invesco NASDAQ Next Generation 100 Acc - USD0.91%1.37%-NC
Invesco Nasdaq Next Gen 100 ETF - USD0.9%2.55%-NC
First Trust International IPO ETF - USD0.86%3.69%Welt
Vident International Equity Fund - USD0.5%2.74%-Welt
Global X S&P Catholic Values Developed ex-U...0.39%2.77%-NC
Global X Thematic Growth ETF - USD0.38%1.51%-NC
American Century�Quality Divers...0.31%3.03%Welt
Goldman Sachs Innovate Equity ETF - USD0.26%2.38%-NC
Amundi Prime Eurozone DR (D) - EUR0.26%1.92%-NC
Amundi Prime Eurozone DR (C) - EUR0.26%2.21%-NC
Xtrackers Europe Net Zero Pathway Paris Ali...0.19%2.07%-NC
Xtrackers S&P Europe ex UK 1D - EUR0.17%0.00%Europa
Amundi Prime Europe DR (C) - EUR0.12%2.10%-Europa
AMUNDI PRIME EUROPE - - EUR0.12%2.10%Europa
Fidelity NASDAQ Composite Index ETF - USD0.07%2.25%-United States
Invesco RAFI Strategic US ETF - USD0.06%2.74%United States
AMUNDI PRIME GLOBAL - - USD0.02%1.56%Welt
Amundi Prime Global DR (C) - USD0.02%1.59%-Welt



Copyright © 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (“Information”) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Schwerpunkt
BioNTech SE: Der Tag danach
Chart BIONTECH SE
Dauer : Zeitraum :
BioNTech SE : Chartanalyse BioNTech SE | MarketScreener
Vollbild-Chart
Ergebnisentwicklung
Analystenschätzung
Verkaufen
Kaufen
Durchschnittl. Empfehlung AUFSTOCKEN
Anzahl Analysten 15
Letzter Schlusskurs 112,40 €
Mittleres Kursziel 169,78 €
Abstand / Durchschnittliches Kursziel 51,1%
Chart BIONTECH SE
Dauer : Zeitraum :
BioNTech SE : Chartanalyse BioNTech SE | MarketScreener
Vollbild-Chart
Branche und Wettbewerber
01.01.Wert (M$)
BIONTECH SE-18.41%29 539
REGENERON PHARMACEUTICALS, INC.13.56%86 608
VERTEX PHARMACEUTICALS8.10%80 254
WUXI APPTEC CO., LTD.-1.85%34 784
GENMAB A/S-12.55%24 559
BEIGENE, LTD.-0.79%22 778
Die Börse für alle und jeden
100% kostenlose Registrierung
fermer